High Court sides with generic drug makers in narrow ruling – 06/23/11
The Supreme Court issued a troubling decision that stands as a direct threat to consumer protection within the pharmaceutical industry. The Court determined that generic drug companies do not share the same level of responsibility as makers of brand-name equivalents, to update their warning labels when significant new risks emerge. Generic drugs now account for more than 70% of prescriptions filled in the U.S. The Court’s decision to shield generic drug companies from liability goes against precedent and public policy.